Keyphrases
Active Surveillance
60%
Small Renal Mass
60%
Renal Cell Carcinoma
34%
Prostate Cancer
30%
Radical Prostatectomy
28%
Partial Nephrectomy
27%
Radical Cystectomy
27%
Localized Kidney Cancer
26%
Clinically Localized
25%
Renal Mass
24%
Head-and-neck
24%
Delayed Intervention
23%
Surgeons
23%
Radical Nephrectomy
22%
Surveillance Strategy
20%
Upper Aerodigestive Tract Cancer
20%
Cancer-specific Survival
19%
Meta-analysis
19%
Postoperative Outcomes
18%
Intermediate Risk
17%
Tumor
17%
Bladder Cancer
17%
Metastasis
17%
Systematic Meta-analysis
17%
High-risk Men
17%
Upper Tract Urothelial Carcinoma
17%
Natural History
17%
Robot-assisted Partial Nephrectomy
17%
Confidence Interval
16%
Practice Patterns
14%
Renal Tumor
14%
Oncological Outcomes
13%
TNM Staging
13%
Localized Renal Cell Carcinoma
12%
Renal Outcome
12%
Urothelial Carcinoma
12%
Upper Aerodigestive Tract
12%
Prospective Cohort Study
12%
Distant Metastasis
12%
Management Strategy
12%
Thermal Ablation
12%
Operative Time
11%
Nephrectomy
11%
Patient Selection
11%
Composite Model
11%
Testicle
11%
Robotic Partial Nephrectomy
11%
Systematic Literature Review
11%
Metastatic Renal Cell Carcinoma (mRCC)
11%
Lymphadenectomy
11%
Medicine and Dentistry
Kidney Tumour
100%
Partial Nephrectomy
56%
Clear Cell Renal Cell Carcinoma
49%
Neoplasm
48%
Systematic Review
34%
Transitional Cell Carcinoma
32%
Malignant Neoplasm
30%
Prostate Cancer
30%
Surgeon
29%
Cystectomy
28%
Radical Nephrectomy
24%
Metastatic Carcinoma
23%
Biopsy Technique
23%
Prostatectomy
22%
Diseases
20%
Neck
20%
Cancer Specific Survival
19%
Meta-Analysis
18%
Cancer
18%
Bladder Cancer
17%
Kidney Function
17%
Overall Survival
16%
Nephrectomy
13%
Decision Making
13%
Prospective Cohort Study
12%
Carcinoma
12%
Operation Duration
12%
Distant Metastasis
12%
Surgery
11%
Pediatrics
11%
Neoadjuvant Chemotherapy
11%
Testes
11%
Retroperitoneal Lymph Node Dissection
11%
Quality of Life
11%
Cystoscopy
10%
Recurrent Disease
9%
Glomerular Filtration Rate
9%
Head and Neck Surgery
9%
Lymph Node
9%
Nephroureterectomy
9%
Bleeding
8%
Urologist
8%
Biological Marker
8%
Kidney Metastasis
8%
Learning Curve
8%
Kidney Cancer
8%
Infection
7%
Physical Examination
7%
Biochemical Recurrence
7%
Proportional Hazards Model
7%